Clinical Trials Directory

Trials / Unknown

UnknownNCT04635488

Prediction Model for Lateral Lymph Node Metastasis

Radiomics-based Prediction Model for Lateral Lymph Node Metastasis in Rectal Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Mid to low-lying rectal cancer patient with enlarged lateral lymph node befor treatment and receiving lateral lymph node dissection would be enrolled. Radiomics parameters of lateral lymph nodes would be extracted by expert software. Then a part of the nodes would be used as the training set to build the prediction model, and the another part nodes would be used as the validation set.

Detailed description

After performing lateral lymph node dissection for the enrolled patients, we would find the targeted lateral node which was matched with the enlarged one in imaging from the specimen. Then the nodes would be send for pathological examination. Then we would extract the radiomics parameters of the nodes from the pretreatment CT and MRI with ITK-SNAP software. According to the pathological status, lymph nodes and corresponding radiomics parameters would be divided into positive and negative groups. Then significant parameters would be selected by R software. Then the prediction model with nomogram would be developed. 70% nodes would be used for for model development and the other 30% would be used for validation.

Conditions

Interventions

TypeNameDescription
PROCEDURElateral lymph node dissectionAll participted would receive lateral lymph node dissection for rectal cancer.

Timeline

Start date
2020-01-01
Primary completion
2021-06-30
Completion
2022-12-31
First posted
2020-11-19
Last updated
2020-11-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04635488. Inclusion in this directory is not an endorsement.